KIMBERLEY WESOLOWSKI: Open Payments
NPI 1003699364 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 31 payments from 16 companies in 2025. Trend: 2023 $88 · 2024 $960 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $172 |
| Abbott Laboratories | 1 | $147 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| PFIZER INC. | 5 | $107 |
| AGEPHA Pharma FZ LLC | 1 | $99 |
| BridgeBio Pharma, Inc. | 1 | $68 |
| Alnylam Pharmaceuticals Inc. | 2 | $58 |
| SCPHARMACEUTICALS INC. | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $49 |
Products named: Wegovy, CARDIOMEMS, LEQVIO, VYNDAQEL, LODOCO, Attruby, ONPATTRO, FUROSCIX.
Industry payments across PA — which companies pay providers there.
